{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T21:09:25Z","timestamp":1792444165186,"version":"4.5.0"},"reference-count":46,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2007,8,1]],"date-time":"2007-08-01T00:00:00Z","timestamp":1185926400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"published-print":{"date-parts":[[2007,8]]},"DOI":"10.1016\/j.pnpbp.2007.04.017","type":"journal-article","created":{"date-parts":[[2007,5,2]],"date-time":"2007-05-02T14:37:23Z","timestamp":1178116643000},"page":"1219-1223","source":"Crossref","is-referenced-by-count":24,"title":["Usefulness of long-acting injectable risperidone during 12-month maintenance therapy of bipolar disorder"],"prefix":"10.1016","volume":"31","author":[{"given":"Changsu","family":"Han","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moon-Soo","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi-Un","family":"Pae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young-Hoon","family":"Ko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashwin A.","family":"Patkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"In-Kwa","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pnpbp.2007.04.017_bib1","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1097\/00131746-200609000-00002","article-title":"Predictors of relapse in bipolar disorder: a review","volume":"12","author":"Altman","year":"2006","journal-title":"J Psychiatr Pract"},{"key":"10.1016\/j.pnpbp.2007.04.017_bib2","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1159\/000284591","article-title":"The brief psychiatric rating scale. Dimension of schizophrenia\u2014reliability and construct validity","volume":"22","author":"Andersen","year":"1989","journal-title":"Psychopathology"},{"key":"10.1016\/j.pnpbp.2007.04.017_bib3","first-page":"25","article-title":"Psychosocial determinants of lithium compliance in patients with bipolar disorder","volume":"31","author":"Bonin","year":"1999","journal-title":"Can J Nurs Res"},{"key":"10.1016\/j.pnpbp.2007.04.017_bib4","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1136\/ebmh.10.1.13","article-title":"Continuing aripiprazole after stabilisation of a manic or mixed episode of bipolar I disorder delays relapse","volume":"10","author":"Chou","year":"2007","journal-title":"Evid Based Ment Health"},{"key":"10.1016\/j.pnpbp.2007.04.017_bib5","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.schres.2005.02.013","article-title":"Manual for the Extrapyramidal Symptom Rating Scale (ESRS)","volume":"76","author":"Chouinard","year":"2005","journal-title":"Schizophr Res"},{"key":"10.1016\/j.pnpbp.2007.04.017_bib6","doi-asserted-by":"crossref","first-page":"549","DOI":"10.4088\/JCP.v61n0802","article-title":"Clinical factors associated with treatment noncompliance in euthymic bipolar patients","volume":"61","author":"Colom","year":"2000","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pnpbp.2007.04.017_bib7","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.4088\/JCP.v64n0917","article-title":"Psychoeducation efficacy in bipolar disorders: beyond compliance enhancement","volume":"64","author":"Colom","year":"2003","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pnpbp.2007.04.017_bib8","doi-asserted-by":"crossref","first-page":"741","DOI":"10.2165\/00003495-199447050-00004","article-title":"Depot antipsychotic Drugs. Place in therapy","volume":"47","author":"Davis","year":"1994","journal-title":"Drugs"},{"key":"10.1016\/j.pnpbp.2007.04.017_bib9","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1097\/01.pra.0000265764.87376.02","article-title":"Medication adherence and the use of long-acting antipsychotics in bipolar disorder","volume":"13","author":"El-Mallakh","year":"2007","journal-title":"J Psychiatr Pract"},{"key":"10.1016\/j.pnpbp.2007.04.017_bib10","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1192\/bjp.148.6.723","article-title":"Comparison of the prophylactic action of flupenthixol with placebo in lithium treated manic-depressive patients","volume":"148","author":"Esparon","year":"1986","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.pnpbp.2007.04.017_bib11","doi-asserted-by":"crossref","first-page":"591","DOI":"10.2165\/00023210-200620070-00004","article-title":"Economics of atypical antipsychotics in bipolar disorder: a review of the literature","volume":"20","author":"Fleurence","year":"2006","journal-title":"CNS Drugs"},{"key":"10.1016\/j.pnpbp.2007.04.017_bib12","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1475-2832-3-4","article-title":"Off-label indications for atypical antipsychotics: a systematic review","volume":"3","author":"Fountoulakis","year":"2004","journal-title":"Ann Gen Hosp Psychiatry"},{"issue":"Suppl 9","key":"10.1016\/j.pnpbp.2007.04.017_bib13","first-page":"49","article-title":"Antipsychotics in bipolar disorder","volume":"57","author":"Gelenberg","year":"1996","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pnpbp.2007.04.017_bib14","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1097\/01.jcp.0000246217.34024.53","article-title":"Extrapyramidal adverse events associated with atypical antipsychotic treatment of bipolar disorder","volume":"27","author":"Gentile","year":"2007","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.pnpbp.2007.04.017_bib15","doi-asserted-by":"crossref","first-page":"222","DOI":"10.4088\/JCP.v67n0208","article-title":"Treatment adherence among patients with bipolar or manic disorder taking atypical and typical antipsychotics","volume":"67","author":"Gianfrancesco","year":"2006","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pnpbp.2007.04.017_bib16","series-title":"US Dept Health, Education, and Welfare publication (ADM)","first-page":"218","article-title":"ECDEU Assessment Manual for Psychopharmacology","author":"Guy","year":"1976"},{"key":"10.1016\/j.pnpbp.2007.04.017_bib17","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1136\/jnnp.23.1.56","article-title":"A rating scale for depression","volume":"23","author":"Hamilton","year":"1960","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.pnpbp.2007.04.017_bib18","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1185\/135525706X75267","article-title":"Satisfaction of patients and caregivers with long-acting injectable risperidone and oral atypical antipsychotics","volume":"10","author":"Han","year":"2005","journal-title":"Prim. Care Community Psychiatry"},{"key":"10.1016\/j.pnpbp.2007.04.017_bib19","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1001\/archpsyc.1979.01780120013001","article-title":"Fluphenazine and social therapy in the aftercare of schizophrenic patients. Relapse analyses of a two-year controlled study of fluphenazine decanoate and fluphenazine hydrochloride","volume":"36","author":"Hogarty","year":"1979","journal-title":"Arch Gen Psychiatry"},{"issue":"Suppl 16","key":"10.1016\/j.pnpbp.2007.04.017_bib20","first-page":"34","article-title":"Strategies for improving compliance in treatment of schizophrenia by using a long-acting formulation of an antipsychotic: clinical studies","volume":"64","author":"Kane","year":"2003","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pnpbp.2007.04.017_bib21","first-page":"147","article-title":"Factors associated with maintenance antipsychotic treatment of patients with bipolar disorder","volume":"57","author":"Keck","year":"1996","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pnpbp.2007.04.017_bib22","first-page":"87","article-title":"Compliance with maintenance treatment in bipolar disorder","volume":"33","author":"Keck","year":"1997","journal-title":"Psychopharmacol Bull"},{"key":"10.1016\/j.pnpbp.2007.04.017_bib23","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1176\/appi.ajp.160.9.1651","article-title":"A placebo-controlled, double-blind study of the efficacy and safety of aripiprazole in patients with acute bipolar mania","volume":"160","author":"Keck","year":"2003","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pnpbp.2007.04.017_bib24","doi-asserted-by":"crossref","first-page":"626","DOI":"10.4088\/JCP.v67n0414","article-title":"A randomized, double-blind, placebo-controlled 26-week trial of aripiprazole in recently manic patients with bipolar I disorder","volume":"67","author":"Keck","year":"2006","journal-title":"J Clin Psychiatry"},{"issue":"Suppl 10","key":"10.1016\/j.pnpbp.2007.04.017_bib25","first-page":"23","article-title":"Antidepressants and antipsychotics in the long-term treatment of bipolar disorder","volume":"63","author":"Kusumakar","year":"2002","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pnpbp.2007.04.017_bib26","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1002\/hup.782","article-title":"Long-term treatment with long-acting risperidone in Korean patients with schizophrenia","volume":"21","author":"Lee","year":"2006","journal-title":"Hum Psychopharmacol"},{"key":"10.1016\/j.pnpbp.2007.04.017_bib27","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1097\/00004850-200507000-00004","article-title":"Minimal injection site pain and high patient satisfaction during treatment with long-acting risperidone","volume":"20","author":"Lindenmayer","year":"2005","journal-title":"Int Clin Psychopharmacol"},{"key":"10.1016\/j.pnpbp.2007.04.017_bib28","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1192\/bjp.165.6.827","article-title":"Depot antipsychotics in the prophylaxis of bipolar affective disorder","volume":"165","author":"Littlejohn","year":"1994","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.pnpbp.2007.04.017_bib29","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1177\/0269881105056515","article-title":"Long-acting risperidone in stable patients with schizoaffective disorder","volume":"19","author":"Mohl","year":"2005","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.pnpbp.2007.04.017_bib30","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1192\/bjp.136.1.105a","article-title":"Depot injections for affective disorders","volume":"136","author":"Naylor","year":"1980","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.pnpbp.2007.04.017_bib31","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1089\/cap.2006.16.336","article-title":"A one-year open-label trial of risperidone augmentation in lithium nonresponder youth with preschool-onset bipolar disorder","volume":"16","author":"Pavuluri","year":"2006","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"10.1016\/j.pnpbp.2007.04.017_bib32","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.4088\/JCP.v67n1112","article-title":"Olanzapine versus risperidone in the treatment of manic or mixed States in bipolar I disorder: a randomized, double-blind trial","volume":"67","author":"Perlis","year":"2006","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pnpbp.2007.04.017_bib33","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD004999.pub2","article-title":"Risperidone in long-term treatment for bipolar disorder","author":"Rendell","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.pnpbp.2007.04.017_bib34","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1176\/appi.ajp.159.7.1146","article-title":"Combination of a mood stabilizer with risperidone or haloperidol for treatment of acute mania: a double-blind, placebo-controlled comparison of efficacy and safety","volume":"159","author":"Sachs","year":"2002","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pnpbp.2007.04.017_bib35","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1586\/14737175.5.2.177","article-title":"Risperidone for bipolar disorders","volume":"5","author":"Sajatovic","year":"2005","journal-title":"Expert Rev Neurother"},{"key":"10.1016\/j.pnpbp.2007.04.017_bib36","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1097\/01.jcp.0000231609.91144.00","article-title":"Use of long-acting risperidone in the treatment of bipolar patients","volume":"26","author":"Savas","year":"2006","journal-title":"J Clin Psychopharmacol"},{"issue":"Suppl 1","key":"10.1016\/j.pnpbp.2007.04.017_bib37","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.1055\/s-2005-867024","article-title":"Treatment of bipolar mania with risperidone","volume":"33","author":"Schreiner","year":"2006","journal-title":"Psychiatr Prax"},{"key":"10.1016\/j.pnpbp.2007.04.017_bib39","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1176\/ajp.151.1.133","article-title":"Neuroleptic exposure following inpatient treatment of acute mania with lithium and neuroleptic","volume":"151","author":"Sernyak","year":"1994","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pnpbp.2007.04.017_bib38","doi-asserted-by":"crossref","first-page":"193","DOI":"10.4088\/JCP.v58n0503","article-title":"Chronic neuroleptic exposure in bipolar outpatients","volume":"58","author":"Sernyak","year":"1997","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pnpbp.2007.04.017_bib40","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.euroneuro.2004.06.003","article-title":"Acute and continuation risperidone monotherapy in bipolar mania: a 3-week placebo-controlled trial followed by a 9-week double-blind trial of risperidone and haloperidol","volume":"15","author":"Smulevich","year":"2005","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.pnpbp.2007.04.017_bib41","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/0165-0327(95)00084-4","article-title":"A survey of prescribing practice of antipsychotic maintenance treatment for manic-depressive outpatients","volume":"38","author":"Verdoux","year":"1996","journal-title":"J Affect Disord"},{"key":"10.1016\/j.pnpbp.2007.04.017_bib43","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1002\/hup.556","article-title":"Acute and continuation risperidone monotherapy in mania","volume":"19","author":"Vieta","year":"2004","journal-title":"Hum Psychopharmacol"},{"key":"10.1016\/j.pnpbp.2007.04.017_bib42","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1192\/bjp.187.3.235","article-title":"Effectiveness of aripiprazole v. haloperidol in acute bipolar mania: double-blind, randomised, comparative 12-week trial","volume":"187","author":"Vieta","year":"2005","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.pnpbp.2007.04.017_bib44","doi-asserted-by":"crossref","first-page":"172","DOI":"10.4088\/JCP.v59n0405","article-title":"Medication compliance among patients with bipolar disorder and substance use disorder","volume":"59","author":"Weiss","year":"1998","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pnpbp.2007.04.017_bib45","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.psc.2005.01.001","article-title":"Atypical antipsychotics for bipolar disorder","volume":"28","author":"Yatham","year":"2005","journal-title":"Psychiatr Clin North Am"},{"key":"10.1016\/j.pnpbp.2007.04.017_bib46","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1192\/bjp.133.5.429","article-title":"A rating scale for mania: reliability, validity and sensitivity","volume":"133","author":"Young","year":"1978","journal-title":"Br J Psychiatry"}],"container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584607001510?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584607001510?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,7]],"date-time":"2019-01-07T22:20:04Z","timestamp":1546899604000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0278584607001510"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,8]]},"references-count":46,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2007,8]]}},"alternative-id":["S0278584607001510"],"URL":"https:\/\/doi.org\/10.1016\/j.pnpbp.2007.04.017","relation":{},"ISSN":["0278-5846"],"issn-type":[{"value":"0278-5846","type":"print"}],"subject":[],"published":{"date-parts":[[2007,8]]}}}